Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Smith & Nephew PLC Remuneration Information 2024

Dec 6, 2024

4588_def-14a_2024-12-06_0712177b-c18e-4f53-9291-1cf38144d044.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0340P

Smith & Nephew Plc

06 December 2024

SMITH & NEPHEW PLC

6 December 2024

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

On 5 December 2024, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under an award agreement to Deepak Nath. 

VESTING OF A PERFORMANCE AWARD  AND RESTRICTED SHARE AWARDS GRANTED UNDER THE AWARD AGREEMENT DATED 29 APRIL 2022

As set out in the announcement published on 3 May 2022, a Performance Award over 97,360 shares was granted to Deepak Nath with an expected vest date of 12 November 2024. The vest of this award was subject to the performance conditions applicable to the performance stock award over Siemens Healthineers AG ("SH") shares originally granted to Mr Nath by SH on 13 November 2020.

In accordance with the terms of the award agreement, the expected vest date of 12 November 2024 was delayed so that the applicable performance criteria attaching to the Performance Award could be measured against the financial results of SH which were announced on 6 November 2024. It has been determined that, following completion of the performance measurement period, 77.29% of the award vests. 75,254 shares were therefore available for vest with the remaining balance of shares, 22,106, lapsing with immediate effect.

Also as set out in the announcement published on 3 May 2022, Restricted Share Awards over 3,015 shares with an expected vesting date of 8 November 2024 and 4,788 shares with an expected vesting date of 13 November 2024 were granted. The vesting of these awards was delayed to coincide with the vesting of the Performance Share Award described above. Accordingly, awards over a total of 83,057 shares have vested on 5 December 2024.   

Reason for the notification
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
LEI 213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code ISIN: GB0009223206
Nature of the transaction Vest of a Performance Award and Restricted Share Awards granted on 29 April 2022 under the award agreement.
Date of Transaction 2024 - 12 - 5
Place of Transaction London Stock Exchange (XLON)
Name

(Position)
Status Price (£) Volume Aggregated information
Deepak Nath

(Chief Executive Officer)
Director 9.812 83,057 (of which 34,033 shares were sold to cover taxes due and 49,024 shares were retained) N/A Single Transaction

Helen Barraclough

General Counsel & Company Secretary

Smith & Nephew plc

Tel:  +44 (0)1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHQELFBZLLFFBD